These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26366962)

  • 1. Lacosamide Induced Psychosis: Case Report, Review of Differential Diagnosis and Relevant Pharmacokinetics.
    Pinkhasov A; Lam T; Hayes D; Friedman M; Singh D; Cohen H
    Clin Neuropharmacol; 2015; 38(5):198-200. PubMed ID: 26366962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First case of lacosamide-induced psychosis.
    Chatzistefanidis D; Karvouni E; Kyritsis AP; Markoula S
    Clin Neuropharmacol; 2013; 36(1):27-8. PubMed ID: 23334072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in epilepsy treatment: lacosamide pharmacokinetic profile.
    Cawello W; Stockis A; Andreas JO; Dimova S
    Ann N Y Acad Sci; 2014 Nov; 1329():18-32. PubMed ID: 25167889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lacosamide: new adjunctive treatment option for partial-onset seizures.
    Chung SS
    Expert Opin Pharmacother; 2010 Jun; 11(9):1595-602. PubMed ID: 20482307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
    Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN
    Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures.
    Degiorgio CM
    Epilepsy Behav; 2010 Jul; 18(3):322-4. PubMed ID: 20570216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures.
    de Biase S; Valente M; Gigli GL; Merlino G
    Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):997-1005. PubMed ID: 28750560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lacosamide for the treatment of epilepsy.
    de Biase S; Gigli GL; Valente M; Merlino G
    Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):459-68. PubMed ID: 24479852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
    Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lacosamide-induced rash.
    Koubeissi MZ; Vismer M; Ehrlich A
    Epileptic Disord; 2014 Sep; 16(3):380-3. PubMed ID: 25035958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacosamide in patients with pharmacoresistant epilepsy.
    Verrotti A; Loiacono G; Olivieri C; Zulli E; Zaccara G
    Expert Opin Pharmacother; 2012 Oct; 13(14):2065-72. PubMed ID: 22873760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation.
    Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM
    Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism of lacosamide with established antiepileptic drugs in the 6-Hz seizure model in mice.
    Shandra A; Shandra P; Kaschenko O; Matagne A; Stöhr T
    Epilepsia; 2013 Jul; 54(7):1167-75. PubMed ID: 23750855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus.
    Koubeissi MZ; Mayor CL; Estephan B; Rashid S; Azar NJ
    Acta Neurol Scand; 2011 Feb; 123(2):142-6. PubMed ID: 21198444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy.
    Nizam A; Mylavarapu K; Thomas D; Briskin K; Wu B; Saluja D; Wong S
    Epilepsia; 2011 Oct; 52(10):e153-5. PubMed ID: 21801173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the effects of lacosamide on sleep parameters in healthy subjects.
    Hudson JD; Guptill JT; Byrnes W; Yates SL; Williams P; D'Cruz O
    Seizure; 2015 Feb; 25():155-9. PubMed ID: 25468512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.
    Harris JA; Murphy JA
    Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosis induced by zonisamide: a case report and review of the literature.
    Abdoh M; Mersfelder TL; Melgar TA
    Am J Ther; 2014; 21(1):e15-6. PubMed ID: 22020087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.